Press

ProNAi Therapeutics Added to NASDAQ Biotechnology Index

December 18, 2015

ProNAi Therapeutics Appoints Dr. Keith Anderson and Dr. Gregg Smith to its Senior Management Team

December 3, 2015

LiquidCool to Launch New Technology at SC15

November 3, 2015

ProNAi Initiates 'Brighton' Phase II Trial of PNT2258 in Patients with Richter's Transformation

October 29, 2015

ProNAi Therapeutics Announces Closing of IPO and Full Exercise of the Underwriters' Option to Purchase Additional Shares

July 21, 2015

ProNAi Appoints Dr. Barbara Klencke as Chief Development Officer

June 23, 2015

ProNAi Appoints Dr. Nicole Onetto and Mr. Robert Pelzer to its Board of Directors

June 18, 2015

AdvancePath Academics, Inc. Announces the Acquisition of the Assets of SHW Enterprises, LLC dba ScholarCentric

May 15, 2015

ProNAi Strengthens Leadership Team; Opens Vancouver Corporate Headquarters

June 16, 2015

Winner of the IOT / M2M Innovation World Cup 2014/15 Healthcare Category [OnKöl]

March 12, 2015

ProNAi Initiates Phase II Trial of PNT2258 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

January 7, 2015

Contact

10556 N Port Washington Rd
Ste 201
Mequon, WI 53092

(414) 453-4488